B56.1

Clinical Causes: Infection with Trypanosoma brucei rhodesiense, a parasitic protozoan Transmission through bites of infected tsetse flies (Glossina species) Geographical prevalence mainly in East African countries such as Uganda, Tanzania, and Malawi Exposure through outdoor activities in endemic regions Potential for sporadic cases in regions where the vector is present

Key Symptoms: Fever that comes and goes, often accompanied by chills Severe headaches and body aches Swollen lymph nodes, especially around the neck Muscle and joint pain Fatigue and weakness Skin reactions or rashes at the bite site In later stages, neurological symptoms such as confusion, sleep disturbances, and behavioral changes Potential development of neurological decline if the disease advances

Diagnosis Path: Diagnosis of Rhodesiense trypanosomiasis involves a combination of clinical evaluation and laboratory tests. Physicians typically perform blood smears to detect trypanosomes directly, especially during the early stages. Serological tests may support the diagnosis. If neurological involvement occurs, cerebrospinal fluid analysis can help identify the presence of parasites or associated immune responses. Imaging studies are not primary but may be used to assess complications. Detecting the disease early is crucial for effective treatment.

Treatment Protocols: Treatment options revolve around antiparasitic medications specifically targeting Trypanosoma brucei rhodesiense. Common therapies include the use of suramin in early stages and melarsoprol for advanced disease with neurological involvement. Due to potential toxicity, medication administration should be closely supervised by healthcare professionals. Supportive care to manage symptoms and prevent complications is also an important aspect of treatment. Prevention strategies involve avoiding the tsetse fly bites through protective clothing, insect repellents, and controlling the insect population in endemic areas.